Abdominal Compartment Syndrome and Intra-abdominal Ischemia in Patients with Severe Acute Pancreatitis by unknown
ORIGINAL SCIENTIFIC REPORT
Abdominal Compartment Syndrome and Intra-abdominal
Ischemia in Patients with Severe Acute Pancreatitis
M. Smit1 • K. T. Buddingh1,2 • B. Bosma1 • V. B. Nieuwenhuijs2 • H. S. Hofker2 •
J. G. Zijlstra1
Published online: 1 February 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract
Introduction Severe acute pancreatitis may be complicated by intra-abdominal hypertension (IAH), abdominal
compartment syndrome (ACS), and intestinal ischemia. The aim of this retrospective study is to describe the
incidence, treatment, and outcome of patients with severe acute pancreatitis and ACS, in particular the occurrence of
intestinal ischemia.
Methods The medical records of all patients admitted with severe acute pancreatitis admitted to the ICU of a
tertiary referral center were reviewed. The criteria proposed by the World Society of the Abdominal Compartment
Syndrome (WSACS) were used to determine whether patients had IAH or ACS.
Results Fifty-nine patients with severe acute pancreatitis were identified. Intra-abdominal pressure (IAP) mea-
surements were performed in 29 patients (49.2 %). IAH was present in all patients (29/29). ACS developed in 13/29
(44.8 %) patients. Ten patients with ACS underwent decompressive laparotomy. A large proportion of patients with
ACS had intra-abdominal ischemia upon laparotomy: 8/13 (61.5 %). Mortality was high in both the ACS group and
the IAH group.
Conclusion This study confirms that ACS is common in severe acute pancreatitis. Intra-abdominal ischemia occurs
in a large proportion of patients with ACS. Swift surgical intervention may be indicated when conservative measures
fail in patients with ACS. National and international guidelines need to be updated so that routine IAP measurements
become standard of care for patients with severe acute pancreatitis in the ICU.
Abbreviations
ACS Abdominal compartment syndrome
ERCP Endoscopic retrograde cholangiopancreatography
IAP Intra-abdominal pressure
IAH Intra-abdominal hypertension
ICU Intensive care unit
IQR Inter-quartile range
MOF Multiple organ failure
SAP Severe acute pancreatitis
SD Standard deviation
VARD Video-assisted retroperitoneal debridement
WSACS World Society of the Abdominal Compartment
Syndrome
Introduction
Acute pancreatitis is a well-established risk factor for intra-
abdominal hypertension (IAH) and abdominal compart-
ment syndrome (ACS) [1]. The incidence of IAH in
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patients with severe acute pancreatitis is approximately
60 % [2, 3], while ACS may occur in approximately 30 %
[2]. The mortality of patients with severe acute pancreatitis
who develop ACS is high at 50–75 % [2–4].
Respiratory, renal, and cardiovascular organ failures
have been reported in patients with ACS. Furthermore,
ACS may cause mesenteric hypoperfusion and subsequent
ischemia of intra-abdominal organs [5]. Mesenteric ische-
mia and necrosis may also develop in severe acute pan-
creatitis [6]. Ischemia–reperfusion injury due in IAH and
ACS has mainly been studied in animal models [7–9]. In a
retrospective series in 26 children with ACS, 19 %
required bowel resection due to ischemic necrosis [10].
Furthermore, raised IAP may be an important mechanism
behind colonic hypoperfusion after ruptured aortic aneur-
ysm repair [11]. However, there has not yet been a series
detailing the occurrence of mesenteric ischemia in patients
with severe acute pancreatitis and ACS.
The aim of this study is to describe the incidence,
treatment, and outcome of patients with severe acute pan-
creatitis and ACS in the intensive care unit (ICU), in par-
ticular the occurrence of intestinal ischemia.
Materials and methods
Definitions
Severe acute pancreatitis (SAP)
Acute pancreatitis with persistent organ failure ([48 h) as
defined by the revised Atlanta criteria [12].
Multiple organ failure (MOF)
The failure of[1 organ system (respiratory, renal, or car-
diovascular) [12].
Intra-abdominal hypertension (IAH)
A sustained or repeated pathological elevation in IAP of
12 mmHg or higher [1] categorized into grade I (IAP
12–15 mmHg), grade II (16–20 mmHg), grade III
(21–25 mmHg), and grade IV ([25 mmHg).
Abdominal compartment Syndrome (ACS)
A sustained IAP[20 mmHg that is associated with new
organ dysfunction/failure, as defined by the World Society
of the Abdominal Compartment Syndrome (WSACS) [1].
Patients
This study was conducted at a tertiary referral center for
patients with severe acute pancreatitis. Patients were
included who met the following criteria: (1) who were
admitted to the ICU between January 2005 and May 2011
and (2) who met the revised Atlanta criteria for severe
acute pancreatitis.
Patients were excluded if they met any of the fol-
lowing criteria: (1) age under 18 years; (2) history of
chronic pancreatitis; (3) admission after resuscitation for
cardiac arrest; and (4) pancreatitis was diagnosed post-
mortem. Furthermore, one patient was excluded because
the medical records were incomplete. Medical records of
all patients were examined; this included examination of
the daily nursing charts where intra-abdominal pressure
(IAP) measurements are noted, the admission notes and
ICU discharge notes, the discharge notes of the general
ward, all surgery reports, and all microbiologic culture
reports.
Transvesical IAP measurement was performed accord-
ing to a standard protocol based on the WSACS consensus
definitions [1].
Statistical analysis
Descriptive statistics were used. Dichotomous data were
presented by proportions and continuous data by means
(with standard deviations) or medians (with rages)
according to normality. Pearson’s v2 test, paired and
independent Student T tests, and Mann–Whitney tests were
used as appropriate. Due to small numbers of events,
multivariate analysis was deemed inappropriate.
Results
Patient characteristics
Fifty-nine patients were identified that met the inclusion
criteria. Most patients were males, around 60 years old and
referred from a regional hospital. The mean interval
between admission to a (regional) hospital and the tertiary
ICU was 13.4 days (SD 20.7, range 0–123). The most
common etiology was gallstones (40.7 %), followed by
alcoholic pancreatitis (22.0 %). Most patients were criti-
cally ill; 84.7 % had MOF and 62.7 % had infected pan-
creatic necrosis at some point during their illness.
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Intra-abdominal pressure
Patient characteristics and IAP measurements are summa-
rized in Table 1. IAP measurement was performed in 29
out of 59 patients (49.2 %). Age and Apache II scores did
not differ significantly between the group where IAP was
measured, compared to where no IAP measurements were
done. The mean interval between admission to a (regional)
hospital and the tertiary ICU was 9.3 days in the first group
and 17.2 days in the second group.
The rates of respiratory failure, shock requiring vaso-
pressors, and renal failure were all significantly higher in
the IAP group. All patients in whom IAP was measured
had IAH, and 13/29 (44.8 %) met the criteria for ACS.
Patient characteristics were compared between patients
who developed ACS and those who did not (Table 2). Age,
gender, and APACHE II scores upon admission were
comparable between the two groups. The interval between
hospital admission and tertiary ICU admission was sig-
nificantly shorter in the ACS group.
Treatment of ACS
Most patients with pancreatitis developed ACS within the
first week of hospitalization. Three patients with ACS
underwent conservative treatment (Table 3). One of these
patients died within 2 days of admission to the ICU;
autopsy revealed extensive ischemia of the small and large
intestines. The other two patients recovered from ACS
without surgery.
Decompressive laparotomy was performed in 10
patients with ACS. The mean time between hospital
admittance and decompressive laparotomy was 6.5 days
(SD 5.5; range 1.9–15.5 days). The range in time between
diagnosis of ACS and decompressive surgery was 2–176 h,
with a median of 12 h. A further two patients were reported
to have undergone decompressive laparotomy but did not
meet the criteria for ACS according to the WSACS. The
decision to perform a decompressive laparotomy in these
patients was made on clinical grounds other than IAP
measurements, and they are therefore not analyzed in the
Table 1 Patient characteristics: IAP measurements versus no IAP measurements
IAP measurements No IAP measurements p value
Number of patients 29 30
Female gender 7 16 0.042
Age, mean ± SD 59.6 ± 13.9 61.8 ± 13.6 0.557
Apache II score, mean ± SD 26.6 ± 7.3 26.1 ± 11.8 0.849
Interval between hospital admission and tertiary
ICU admission in days, mean ± SDa
9.3 ± 12.2 17.2 ± 26.0 0.144
Any organ failure 29 (100 %) 25 (83.3 %) 0.067
Respiratory failure 29 (100 %) 24 (80 %) 0.035
Shock requiring vasopressors 27 (93.1 %) 19 (63.3 %) 0.015
Renal failure 24 (82.8 %) 15 (50 %) 0.017
Known bowel ischemia 9 2 0.039
Mortality 11 11 1.0
Days between ICU admission and first IAP measurement, median (IQR) 1 (0–26) N/A
Highest IAP in mmHg, mean ± SD 24 ± 5 N/A
Meets criteria for IAHb 29 (100 %) N/A
Grade I 3 (10.3 %)
Grade II 4 (13.8 %)
Grade III 9 (31.0 %)
Grade IV 13 (44.8 %)
Meets criteria for ACSc 13 (44.8) N/A
Days between ICU admission and diagnosis of ACS, median (IQR) 1 (0–13) N/A
SD standard deviation, ICU intensive care unit, IQR inter-quartile range, IAP intra-abdominal pressure, IAH intra-abdominal hypertension, ACS
abdominal compartment syndrome
a Hospital admission includes ICU admission in a non-tertiary center
b Criteria for IAH: grade I sustained IAP 12–15 mmHg, grade II sustained IAP 16–20 mmHg, grade III sustained IAP 21–25 mmHg, grade IV
sustained IAP[25 mmHg
c Criteria for ACS: sustained IAP[20 and new or progressive organ failure
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ACS group. The most frequently used surgical approach
was full thickness transverse subcostal laparotomy (bilat-
eral in six cases and unilateral in one case); a midline
laparotomy was performed in the other three patients. The
subcostal laparotomy is a preferred approach for decom-
pression in pancreatitis patients in this center since it pro-
vides easy access to the pancreas if necessary at a later
stage. Lactate measurements were increased pre-opera-
tively in four of seven patients with ACS and ischemia in
whom decompressive surgery was performed (Table 3).
The patient with liver ischemia was managed conser-
vatively; bowel ischemia was resected in five patients.
Effect of decompressive laparotomy
The mean IAP before surgery was 27 ± 3 mmHg, and this
decreased to 18 ± 4 mmHg immediately after decom-
pression (p = 0.001). There was an improvement in the
respiratory and/or hemodynamic condition immediately
after decompression in four patients (Table 3). However,
four patients had a persistently high IAP[20 mmHg after
decompressive surgery. In three patients, decompression
had been performed using a bilateral subcostal incision and
in one patient with a midline laparotomy. One patient had a
relaparotomy one day after decompression with resection
of ischemic cecum and left colon. Afterward, IAP
decreased to 17 mmHg. One patient had a necrotic ileost-
omy for which partial ileum resection and a new ileostomy
was placed. Two patients were managed conservatively at
first but required multiple relaparotomies in the course of
their disease. These patients both died from sepsis and
multi-organ failure secondary to SAP. One other patient
required a relaparotomy one day after decompression. This
patient had been too hemodynamically unstable in the
operating theater to continue the operation after decom-
pression and was stabilized in the ICU first. This patient
had necrosis of the sigmoid colon and two gastric
perforations.
Table 2 Comparison between patients with IAP measurements who did and did not develop ACS
No ACS (n = 16) ACS (n = 13) p
Characteristics
Female gender 4 (25.0 %) 3 (23 %) 1.00
Age, mean ± SD 64 ± 12 55 ± 15 0.098
APACHE II score, mean ± SD 26 ± 5 28 ± 10 0.650
Interval between hospital admission and tertiary
ICU admission in days, mean ± SD
13.6 ± 14.6 3.8 ± 4.1 0.020
Grade of IAH
Grade I 3 (18.8 %) 0
Grade II 4 (25.0 %) 0
Grade III 4 (25.0 %) 5 (38.5 %)
Grade IV 5 (31.3 %) 8 (61.5 %)
Any organ failure 16 (100 %) 13 (100 %) 1.00
Respiratory failure 16 (100 %) 13 (100 %) 1.00
Shock requiring vasopressors 14 (87.5 %) 13 (100 %) 0.488
Renal failure 11 (68.8 %) 13 (100 %) 0.048
Multiple organ failure 15 (93.8 %) 13 (100 %) 1.00
Infected pancreatic necrosis 12 (75.0 %) 9 (69.2 %) 1.00
Surgical treatment
Radiological drainage 9 (56.3 %) 8 (61.5 %) 0.774
VARD 6 (37.5 %) 8 (61.5 %) 0.198
Necrosectomy via laparotomy 6 (37.5 %) 2 (15.4 %) 0.238
Decompression laparotomy 2 (12.5 %) 10 (76.9 %) <0.001
Outcome
Bowel perforation or fistula 6 (37.5 %) 6 (46.2 %) 0.638
Gastrointestinal ischemia or necrosis 1 (6.3 %) 8 (61.5 %) 0.003
Length of ICU stay in days, median (IQR) 21 (4–86) 48 (1–135) 0.116
Mortality 4 (25.0 %) 7 (53.8 %) 0.143
SD standard deviation, IAH intra-abdominal hypertension, ACS abdominal compartment syndrome, VARD video-assisted retroperitoneal
debridement
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Intra-abdominal ischemia and outcome
Although there was significantly more shock requiring
vasopressors in the group where IAP was measured
(p = 0.015, Table 1), there was no significant difference in
the occurrence of shock requiring vasopressors in ACS
compared to the group without ACS (Table 2). Renal
failure was present significantly more in patients with ACS
(100 vs. 68.8 %, p = 0.048). The majority of patients in
both groups developed infected pancreatic necrosis at some
point during admission. Enteric fistulae and/or perforations
were seen at similar rates in patients with and without
ACS.
Intra-abdominal ischemia occurred in 11 of 59 patients
(18.6 %). This was significantly higher in patients with
ACS. In nine patients, IAP measurements had taken place;
eight of these patients had ACS (Table 2). The location of
ischemia varied (Table 4).
One patient died after conservative management of
ACS. Autopsy revealed extensive small bowel ischemia
(Table 4). The mortality in patients after decompressive
surgery was 6/10 (60 %). Five of these patients (83 %) had
been diagnosed with intra-abdominal ischemia upon
decompressive laparotomy. Only two patients with ische-
mia survived until discharge from the ICU. One of these
patients was subsequently discharged from the hospital and
recovered fully. The other patient was transferred to
another hospital and died following a neurological com-
plication 3 months later. One patient with ACS died after
supportive treatment was withdrawn after decompressive
laparotomy showed extensive ischemia (Table 3). The five
other patients died 28–68 days after surgery; four deaths
were due to sepsis and multiple organ failure, and one
death was due to bleeding complications (Table 4).
One patient with intra-abdominal ischemia had no ACS.
This patient developed ischemia of the cecum one day after
a laparotomy for drainage of an infected pseudocyst which
was complicated by diffuse bleeding. This patient died
from septic complications following multiple relaparo-
tomies. In two patients with intra-abdominal ischemia, no
IAP had been measured. One patient died from MOF
within 1 day of hospitalization. Autopsy showed extensive
ischemia to small intestines and colon. The other patient
underwent resection of jejunum ischemia after developing
acute abdominal pain one week after discharge from the
ICU. This patient subsequently improved but died in hos-
pital 1 month later due to withholding of therapy in sepsis.
Discussion
This study found that IAH and ACS are common in
patients with severe acute pancreatitis, confirming earlier
series [2, 3]. As a novel finding, a high incidence of



























4 2 3.2 3.5 Absent Yes, respiratory and diuresis
No hemodynamic improvement
5 176 0.8 0.8 Absent No
6 4 1.4 2.7 Absent Yes, respiratory
7 10 6.4 4.1 Present No, persistent high IAP. Relaparotomy: ileum resection and
new stoma
8 19.5 1.6 1.5 Present Yes, respiratory and hemodynamic. IAP persistent high.
9 23.5 1.1 1.9 Present No
10 37 6.4 11.5 Present Yes, respiratory. Hemodynamics very unstable, relaparotomy:
sigmoid necrosis, 2 gastric perforations
11 2 9.2 Present No, treatment withdrawal and death
12 14 8.3 9.2 Present No, persistent high IAP
13 2 2.4 2.2 Present No, persistent high IAP. Relaparotomy: Ischemia left colon
and coecum
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intestinal ischemia was observed in patients with pancre-
atitis and ACS.
IAH was present in all patients in whom IAP was
measured. In previous series, IAH was found in approxi-
mately 60 % of the patients studied [2, 3]. The high rate in
our study may be an overestimation resulting from selec-
tive IAP measurements in patients at risk for IAH; how-
ever, it may also be a reflection of the severity of illness of
patients referred to our tertiary center.
In this series, patients were admitted to a tertiary ICU
after a mean interval of 13.4 days after hospitalization for
the current episode of pancreatitis. In patients with ACS,
this interval was a much shorter 3.8 days. Although the
exact mechanisms are not completely understood, IAH in
severe acute pancreatitis is usually an early phenomenon
and may have an important role in the development of
early organ failure [13].
Decompression laparotomy was successful in lowering
the IAP in most cases. However, the mortality rate of
severe acute pancreatitis with ACS was high at 54 %. This
is comparable to other series [2, 3]. Mortality was even
higher in the ACS group if intra-abdominal ischemia
occurred (75 %).
A causal relationship between ACS and multiple
organ failure in SAP is yet to be established [14]. It is
likely that IAH is involved to some extent in both
development of necrosis and infection of necrosis [13].
In the current study, there was no difference in infected
pancreatic necrosis rates between patients who did and
did not develop ACS. Mortality in SAP typically occurs
in two phases: an early phase where multiple organ
failure occurs with SIRS, IAH, or ACS and a later phase
where mortality is due to secondary infection and
necrosis [15].
The high rate of intra-abdominal ischemia observed in
patients with pancreatitis and ACS has not been reported
previously. Depending on its level and the overall hemo-
dynamic condition, IAH has been associated with bowel
ischaemia [16]. The small intestine may become damaged
during severe acute pancreatitis, due to microcirculation
disturbance associated with loss of fluids in the ‘‘third
space,’’ hypovolemia, splanchnic vasoconstriction, and
finally ischemia–reperfusion injury [17]. Intestinal damage
and loss of intestinal barrier function occur early in the
course of pancreatitis [18]. IAPs were not reported in this
study. IAH and ACS are associated with gut barrier dys-
function as reflected by greater systemic endotoxin expo-
sure and procalcitonin levels [19].
The association between ACS and intestinal ischemia is
further described in animal studies, showing a significant
decrease in perfusion of intestinal mucosa and mesenteric
arterial blood flow, after IAP was increased [7, 8]. The
current study suggests that IAH may be one of the mech-
anisms associated with intestinal damage early in the
course of SAP. Further study is warranted to confirm this
hypothesis.






1 22 Autopsy findings: Focal ischemia on
serosal and mucosal side of small
bowel
Mucosa of jejunum and colon almost
completely disappeared
Died 2 days after admission to the ICU
7 24 Full necrosis of the sigmoid Transmural ischemic necrosis sigmoid Died 67 days after decompression due to
bleeding complications caused by
pancreatitis
8 26 Dubious signs of ischemia of terminal
ileum
Segmental chronic and acute inflammation
with perforation; concordant with
ischemic enteritis
Died 40 days after decompression due to
sepsis and MOF
9 27 Firm necrosis of the jejunum Severe transmural ischemic enteritis Discharge to ward 134 days after
decompression
10 27 Only necrotic remains of the sigmoid
colon
Transmural necrosis Died 13 days after decompression due to
sepsis and MOF
11 29 Full black necrosis of small and large
intestine
Not available Died several hours after decompression,
after withdrawal of treatment
12 32 Marbled aspect of left liver lobe Not available Died 47 days after decompression, due
to sepsis and MOF
13 32 Patchy and full ischemia of the terminal
ileum; full ischemia of cecum and left
colon
ischemia ileum, cecum and left colon Discharge to ward 16 days after
decompression
Pt nr patient number, ACS abdominal compartment syndrome, ICU intensive care unit, IAP intra-abdominal pressure, MOF multiple organ
failure
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We fully support the WSACS recommendation that
protocolized monitoring of IAP should take place in high-
risk patients, such as those with severe acute pancreatitis to
allow early detection and treatment of IAH and ACS. The
protocol in our center has been adjusted since this retro-
spective series to include monitoring of IAP in all high-risk
patients, and we are currently enrolling patients in a
prospective study to evaluate this change. Furthermore, we
recommend international guidelines for treatment of pan-
creatitis patients be updated to include this recommenda-
tion. Three commonly used guidelines by the British
Society of Gastroenterology [20], the American College of
Gastroenterology [21], and the American Gastroentero-
logical Association [22] do not yet mention the need for
routine IAP measurements.
Once IAH is observed, careful monitoring of IAP and
organ functions needs to take place and measures should be
taken in order to prevent further organ dysfunction and
irreversible damage.
Lactate monitoring seems to be of limited value in
diagnosing intestinal ischemia in ACS. In this series, it was
increased in only four of seven patients with ACS and
intestinal ischemia. Furthermore, increased lactate levels
may be a reflection of other problems than intestinal
ischemia, for example, underresuscitation (Table 3). This
matches conclusions from larger series: normal or
decreasing lactate values by no means rule out ischemia
[23, 24].
If ACS occurs, it may be managed by non-surgical
interventions to lower the pressure or to prevent a further
rise. These interventions may include enteral decompres-
sion with nasogastric or rectal tubes when stomach or colon
are dilated, percutaneous drainage of ascites or fluid col-
lections, prevention of overly aggressive fluid resuscitation,
and neuromuscular blockade as a temporizing measure [1].
These conservative measures were not systematically
employed in this group of patients, although two patients
received neuromuscular blockade in an attempt to stabilize
their respiratory failure in ACS. According to this institu-
tion’s protocol, patients with pancreatitis received enteral
feeding via nasogastric or nasojejunal canulas. At the time,
these patients were treated, the slogan in ACS was still
‘‘open the abdomen and leave it open,’’ compared to cur-
rent opinion where conservative management, if possible,
is preferred to prevent the morbidity and mortality that may
result from an open abdomen.
There are no conservative measures unique to SAP
patients. However, conservative measures that may espe-
cially benefit patients with SAP are prevention of overly
aggressive fluid resuscitation early in the course of the
disease and percutaneous drainage of ascites or other fluid
collections that may complicate SAP.
There is evidence that early decompression may
improve survival [13]. However, as this retrospective series
confirms, mortality is still high in this group [5]. Further-
more, an open abdomen in patients with severe acute
pancreatitis is associated with significant morbidity. A
reasonable strategy may be to perform swift decompression
in patients with multiple organ failure and ACS when
conservative management fails.
It may not be feasible to conduct large multicenter
randomized trials to determine optimal treatment strategies
for patients with severe acute pancreatitis and ACS; how-
ever, large, prospective observational studies may be a
reasonable alternative.
Limitations of this study
This study is limited by its retrospective design and small
numbers. IAP measurements were conducted in a subgroup
of patients. Therefore, it is unclear whether the results can be
extrapolated to the entire population of patients with severe
acute pancreatitis. Furthermore, many of the patients were
referred to our center after having been hospitalized else-
where with no records of IAP measurements.
Conclusion
This study confirms that IAH and ACS are common find-
ings in patients with severe acute pancreatitis. IAH may
worsen the already grim course of severe acute pancreatitis.
High rates of intra-abdominal ischemia were found in
patients with ACS. Early recognition of this potentially
treatable aggravating condition may lead to earlier inter-
vention and hopefully improve the outcome. We advise
routine measurement of IAP in all patients with severe
acute pancreatitis. National and international guidelines on
severe acute pancreatitis need to be updated to include IAP
measurements as standard of care and to alert clinicians to
this potentially lethal complication that requires swift
surgical intervention if conservative measures fail.
Key messages
• Intra-abdominal hypertension and abdominal compart-
ment syndrome are common in patients with severe
acute pancreatitis
• Intra-abdominal ischemia may complicate the course of
pancreatitis and ACS
• Routine measurement of IAP is advised in all patients
with severe acute pancreatitis.
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